Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of piperacillin-tazobactam and meropenem in obese patients
2013-000652-18Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Feb 2013
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of piperacillin + tazobactam and meropenem in bacterial disease (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Optimal beta-lactam dosing in obese patients. Started Feb 2013; status: completed.
02
Drugs
piperacillin + tazobactammeropenem
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2013-000652-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000652-18.